DCA Raids Unlicenced Medical Shops, Seizes Medicines

Hyderabad: Continuing its clampdown on illegal sale and procurement of medicines, the Drugs Control Administration (DCA), Telangana, conducted raids on medical shops and Ayurvedic medicine store at Jangaon and Sircilla for operating illegally without a drug licence.

According to the DCA officials, they conducted raids on a medical shop at Cheetoor Village, Linghala Ghanpur Mandal in Jangaon district.

“K. Rajesh Kumar, the owner of the shop, was illegally operating a medical shop Sri Vinayaka medical and general stores on the premises without a valid drug licence,” the officials said.

According to the officials, they discovered unauthorised stocking of large quantities of medicines for sale. Forty-nine varieties of medicines, including antibiotics, steroids, anti-ulcer drugs, antihypertensives and others, were found stocked for sale. Officials seized stock worth `36,000 during the raid.

In another incident, the DCA found an Ayurvedic medicine named as ‘Shilajit’ circulating in the market with misleading claims on its label that it treats kidney stones and obesity, which is a contravention of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

The Act prohibits advertisement of certain drugs for treatment of certain diseases and disorders. No person shall take part in publication of advertisement regarding the diseases/disorders indicated under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, the officials said.

Related Posts

  • Pharma
  • July 11, 2025
  • 87 views
India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

July:  India’s Glenmark Pharmaceuticals (GLEN.NS), opens new tab said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie (ABBV.N), opens new tab have signed an exclusive licensing agreement…

  • Pharma
  • July 10, 2025
  • 144 views
Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

India stands tall as a pharmaceutical powerhouse, supplying 20% of the world’s generic medicines and nearly 62% of global vaccines. Yet, this success now faces a storm: US President Donald…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Novartis wins approval for first malaria drug for newborns and babies

Novartis wins approval for first malaria drug for newborns and babies